RNA diagnostics: Real-time RT-PCR strategies and promising novel target RNAs

Wiley Interdisciplinary Reviews: RNA

Volumn 2, Issue 1, 2011, Pages 32-41

  Mayer, Günter ^a   Müller, Jens ^b   Lünse, Christina E ^a  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; PRIMER RNA; RNA;

ARTICLE; DISEASE MARKER; DNA SEQUENCE; EXON; GENE AMPLIFICATION; HUMAN; INTRON; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; ANIMAL; BIOLOGICAL MODEL; EVALUATION; GENE TARGETING; METHODOLOGY; MOLECULAR DIAGNOSIS; REVIEW;

ANIMALS; GENE TARGETING; HUMANS; MODELS, BIOLOGICAL; MOLECULAR DIAGNOSTIC TECHNIQUES; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA;

EID: 84858314543     PISSN: 17577004     EISSN: 17577012     Source Type: Journal    
DOI: 10.1002/wrna.46     Document Type: Article

References (71)

1. Li K, Brownley A. Primer design for RT-PCR. Methods Mol Biol 2010, 630:271-299.
2. Freeman WM, Walker SJ, Vrana KE. Quantitative RT-PCR: pitfalls and potential. Biotechniques 1999, 26:112-122, 124-125.
3. Rodriguez-Mallon A, Yamilet C, Juana ML, Aymé O, Antonio M, Mario PE. Competitive RT-PCR strategy for quantitative evaluation of the expression of tilapia (Oreochromis niloticu) growth hormone receptor type i. Biol Proced Online 2009.
4. Higuchi R, Fockler C, Dollinger G, Watson R. Kinetic PCR analysis: real-time monitoring of DNA amplification reactions. Biotechnology (NY) 1993, 11:1026-1030.
5. Mackay IM. Real-time PCR in the microbiology laboratory. Clin Microbiol Infect 2004, 10:190-212.
6. Wong ML, Medrano JF. Real-time PCR for mRNA quantitation. Biotechniques 2005, 39:75-85.
7. Mueller J, Gessner JM, Remberg A, Hoch J, Zerlauth G, Hanfland P. Development, validation and evaluation of a homogenous one-step reverse transcriptase-initiated PCR assay with competitive internal control for the detection of hepatitis C virus RNA. Clin Chem Lab Med 2005, 43:827-833.
8. Dhanasekaran S, Doherty TM, Kenneth J. Comparison of different standards for real-time PCR-based absolute quantification. J Immunol Methods 2010, 354:34-39.
9. Pfaffl MW, Horgan GW, Dempfle L. Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res 2002, 30:e36.
10. Rutledge RG, Stewart D. Assessing the performance capabilities of LRE-based assays for absolute quantitative real-time PCR. PLoS One 5:e9731.
11. Nubling CM, Heiden M, Chudy M, Kress J, Seitz R, Keller-Stanislawski B, Funk MB. Experience of mandatory nucleic acid test (NAT) screening across all blood organizations in Germany: NAT yield versus breakthrough transmissions. Transfusion 2009, 49:1850-1858.
12. Offergeld R, Faensen D, Ritter S, Hamouda O. Human immunodeficiency virus, hepatitis C and hepatitis B infections among blood donors in Germany 2000-2002: risk of virus transmission and the impact of nucleic acid amplification testing. Euro Surveill 2005, 10:8-11.
13. Muller J, Eis-Hübinger AM, Däumer M, Kaiser R, Rox JM, Gürtler L, Hanfland P, Pötzsch B. A novel internally controlled real-time reverse transcription-PCR assay for HIV-1 RNA targeting the pol integrase genomic region. J Virol Methods 2007, 142:127-135.
14. Drosten C, Seifried E, Roth WK. TaqMan 5′-nuclease human immunodeficiency virus type 1 PCR assay with phage-packaged competitive internal control for high-throughput blood donor screening. J Clin Microbiol 2001, 39:4302-4308.
15. Josefsen MH, Lofstrom C, Sommer HM, Hoorfar J. Diagnostic PCR: comparative sensitivity of four probe chemistries. Mol Cell Probes 2009, 23:201-203.
16. Petersen K, Vogel U, Rockenbauer E, Nielsen KV, Kølvraa S, Bolund L, Nexø B. Short PNA molecular beacons for real-time PCR allelic discrimination of single nucleotide polymorphisms. Mol Cell Probes 2004, 18:117-122.
17. Schmittgen TD, Lee EJ, Jiang J, Sarkar A, Yang L, Elton TS, Chen C. Real-time PCR quantification of precursor and mature microRNA. Methods 2008, 44:31-38.
18. Hutvagner G, Zamore PD. A microRNA in a multiple-turnover RNAi enzyme complex. Science 2002, 297:2056-2060.
19. Zeng YW, Eric J, Cullen BR. Both natural and designed micro RNAs can inhibit the expression of cognate mRNAs when expressed in human cells. Mol Cell 2002, 9:1327-1333.
20. Zeng YC, Bryan R. Sequence requirements for micro RNA processing and function in human cells. RNA 2003, 9:112-123.
21. Lee RCF, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 1993, 75:843-854.
22. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297.
23. Abelson JFK, Kenneth Y, O'Roak BJ, Baek DY, Stillman AA, Morgan TM, Mathews CA, Pauls DL, Rasin M-R, Gunel M, et al. Sequence variants in SLITRK1 are associated with Tourette's syndrome. Science 2005, 310:317-320.
24. Caudy AAM, Mike MM, Hannon GJ, Hammond SM. Fragile X-related protein and VIG associate with the RNA interference machinery. Genes Dev 2002, 16:2491-2496.
25. Gregory RI, Yan KP, Amuthan G, Chendrimada T, Doratotaj B, Cooch N, Shiekhattar R. The Microprocessor complex mediates the genesis of microRNAs. Nature 2004, 432:235-240.
26. Blenkiron CM, Eric A. miRNAs in cancer: approaches, aetiology, diagnostics and therapy. Hum Mol Genet 2007, 16:R106-R113.
27. Volinia SC, George A, Liu C-G, Ambs S, Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M, et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A 2006, 103:2257-2261.
28. Mathers CD, Dejan L. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 2006, 3:e442.
29. Lu JG, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA, et al. MicroRNA expression profiles classify human cancers. Nature 2005, 435:834-838.
30. Tam W. The emergent role of microRNAs in molecular diagnostics of cancer. J Mol Diagn 2008, 10:411-414.
31. Keller A, Petra L, Borries A, Wendschlag A, Wucherpfennig F, Scheffler M, Huwer H, Lenhof H-P, Meese E. miRNAs in lung cancer - studying complex fingerprints in patient's blood cells by microarray experiments. BMC Cancer 2009, 9:353.
32. Keller A, Petra L, Lange J, Borries A, Schroers H, Scheffler M, Lenhof H-P, Ruprecht K, Meese E. Multiple sclerosis: microRNA expression profiles accurately differentiate patients with relapsing-remitting disease from healthy controls. PLoS One 2009, 4:e7440.
33. Michael MZ, O' Connor SM, van Holst Pellekaan NG, Young GP, James RJ. Reduced accumulation of specific microRNAs in colorectal neoplasia. Mol Cancer Res 2003, 1:882-891.
34. Metzler M, Monika W, Busch K, Viehmann S, Borkhardt A. High expression of precursor microRNA-155/BIC RNA in children with Burkitt lymphoma. Genes Chromosomes Cancer 2004, 39:167-169.
35. Takamizawa J, Hiroyuki K, Yanagisawa K, Tomida S, Osada H, Endoh H, Harano T, Yatabe Y, Nagino M; Nimura Y, et al. Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res 2004, 64:3753-3756.
36. Eis PS, Wayne T, Sun L, Chadburn A, Li Z, Gomez MF, Lund E, Dahlberg JE. Accumulation of miR-155 and BIC RNA in human B cell lymphomas. Proc Natl Acad Sci U S A 2005, 102:3627-3632.
37. Iorio MV, Manuela F, Liu C-G, Veronese A, Spizzo R, Sabbioni S, Magri E, Pedriali M, Fabbri M, Campiglio M, et al. MicroRNA gene expression deregulation in human breast cancer. Cancer Res 2005, 65:7065-7070.
38. He H, Krystian J, Li W, Liyanarachchi S, Nagy R, Volinia S, Calin GA, Liu C-G, Franssila K, Suster S, et al. The role of microRNA genes in papillary thyroid carcinoma. Proc Natl Acad Sci U S A 2005, 102:19075-19080.
39. Kluiver J, Sibrand P, de Jong D, Blokzijl T, Harms G, Jacobs S, Kroesen B-J, van den Berg A. BIC and miR-155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomas. J Pathol 2005, 207:243-249.
40. Trang PW, Weidhaas JB, Slack FJ. MicroRNAs as potential cancer therapeutics. Oncogene 2008, 27:S52-S57.
41. Lanza G, Manuela F, Gafà R, Veronese A, Spizzo R, Pichiorri F, Liu C-G, Calin GA, Croce CM, Negrini M. mRNA/microRNA gene expression profile in microsatellite unstable colorectal cancer. Mol Cancer 2007, 6:54.
42. Pimiento JM, Desarom T, Malkan A, Dudrick SJ, Palesty JA. Cancer of unknown primary origin: a decade of experience in a community-based hospital. Am J Surg 2007, 194:833-837; discussion 837-838.
43. Rosenfeld N, Ranit A, Meiri E, Rosenwald S, Spector Y, Zepeniuk M, Benjamin H, Shabes N, Tabak S, Levy A, et al. MicroRNAs accurately identify cancer tissue origin. Nat Biotechnol 2008, 26:462-469.
44. Romond EH, Perez EA, Bryant J, Suman VJ, Geyer CE, Davidson NE, Tan-Chiu E, Martino S, Paik S, Kaufman PA, et al. Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer. N Engl J Med 2005, 353:1673-1684.
45. Pao WM, Vincent A. Epidermal growth factor receptor mutations, small-molecule kinase inhibitors, and non-small-cell lung cancer: current knowledge and future directions. J Clin Oncol 2005, 23:2556-2568.
46. Piccart-Gebhart MJ, Marion P, Leyland-Jones B, Goldhirsch A, Untch M, Smith I, Gianni L, Baselga J, Bell R, Jackisch C, et al. Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer. N Engl J Med 2005, 353:1659-1672.
47. Nicoloso MS, Hao S, Spizzo R, Kim H, Wickramasinghe P, Shimizu M, Wojcik SE, Ferdin J, Kunej T, Xiao L, et al. Single-nucleotide polymorphisms inside microRNA target sites influence tumor susceptibility. Cancer Res 2010, 70:2789-2798.
48. Lewis F, Maughan NJ, Smith V, Hillan K, Quirke P. Unlocking the archive-gene expression in paraffin-embedded tissue. J Pathol 2001, 195:66-71.
49. Szafranska AE, Martina D, Timothy S, Shingara J, Doleshal M, Riggenbach JA, Morrison CD, Jewell S, Labourier E. Accurate molecular characterization of formalin-fixed, paraffin-embedded tissues by microRNA expression profiling. J Mol Diagn 2008, 10:415-423.
50. Szafranska AE, Martina D, Edmunds HS, Gordon S, Luttges J, Munding JB, Barth RJ, Gutmann EJ, Suriawinata AA, Pipas JM, et al. Analysis of microRNAs in pancreatic fine-needle aspirates can classify benign and malignant tissues. Clin Chem 2008, 54:1716-1724.
51. Doleshal MM, Amber A, Choudhury B, Cannon BD, Labourier E, Szafranska AE. Evaluation and validation of total RNA extraction methods for microRNA expression analyses in formalin-fixed, paraffin-embedded tissues. J Mol Diagn 2008, 10:203-211.
52. Lee Y, Minju K, Han J, Yeom K-H, Lee S, Baek SH, Kim VN. MicroRNA genes are transcribed by RNA polymerase II. EMBO J 2004, 23:4051-4060.
53. Cai X, Curt H, Cullen BR. Human microRNAs are processed from capped, polyadenylated transcripts that can also function as mRNAs. RNA 2004, 10:1957-1966.
54. Borchert GM, Lanier W, Davidson BL. RNA polymerase III transcribes human microRNAs. Nat Struct Mol Biol 2006, 13:1097-1101.
55. Lee Y, Jeon K, Lee J-T, Kim S, Kim VN. MicroRNA maturation: stepwise processing and subcellular localization. EMBO J 2002, 21:4663-4670.
56. Denli AMT, Bastiaan BJ, Plasterk RHA, Ketting RF, Hannon GJ. Processing of primary microRNAs by the Microprocessor complex. Nature 2004, 432:231-235.
57. Lee Y, Chiyoung A, Han J, Choi H, Kim J, Yim J, Lee J, Provost P, RÃ¥dmark O, Kim S, et al. The nuclear RNase III Drosha initiates microRNA processing. Nature 2003, 425:415-419.
58. Bohnsack MT, Czaplinski K, Gorlich D. Exportin 5 is a RanGTP-dependent dsRNA-binding protein that mediates nuclear export of pre-miRNAs. RNA 2004, 10:185-191.
59. Lund E, Güttinger S, Calado A, Dahlberg JE, Kutay U. Nuclear export of microRNA precursors. Science 2004, 303:95-98.
60. Schwarz DS, Hutvágner G, Du T, Xu Z, Aronin N, Zamore PD. Asymmetry in the assembly of the RNAi enzyme complex. Cell 2003, 115:199-208.
61. Khvorova A, Angela R, Jayasena SD. Functional siRNAs and miRNAs exhibit strand bias. Cell 2003, 115:209-216.
62. Sen GL, Balu HM. Argonaute 2/RISC resides in sites of mammalian mRNA decay known as cytoplasmic bodies. Nat Cell Biol 2005, 7:633-636.
63. Kopreski MS, Benko FA, Gocke CD. Circulating RNA as a tumor marker: detection of 5T4 mRNA in breast and lung cancer patient serum. Ann N Y Acad Sci 2001, 945:172-178.
64. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, Peterson A, Noteboom J, O'Briant KC, Allen A, et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A 2008, 105: 10513-10518.
65. Silva J, García V, García JM, Peña C, Domínguez G, Díaz R, Lorenzo Y, Hurtado A, Sánchez A, Bonilla F. Circulating Bmi-1 mRNA as a possible prognostic factor for advanced breast cancer patients. Breast Cancer Res 2007, 9:R55.
66. Feng G, Li G, Gentil-Perret A, Tostain J, Genin C. Elevated serum-circulating RNA in patients with conventional renal cell cancer. Anticancer Res 2008, 28:321-326.
67. Krutzfeldt J, Rajewsky N, Braich R, Rajeev KG, Tuschl T, Manoharan M, Stoffel M. Silencing of microRNAs in vivo with 'antagomirs'. Nature 2005, 438:685-689.
68. Mattie MDB, Christopher C, Bowers J, Sensinger K, Wong L, Scott GK, Fedele V, Ginzinger D, Getts R, Haqq C. Optimized high-throughput microRNA expression profiling provides novel biomarker assessment of clinical prostate and breast cancer biopsies. Mol Cancer 2006, 5:24.
69. Gaur AJ, David A, Liang Y, Ridzon D, Moore JH, Chen C, Ambros VR, Israel MA. Characterization of microRNA expression levels and their biological correlates in human cancer cell lines. Cancer Res 2007, 67:2456-2468.
70. Zhang B, Xiaoping P, Cobb GP, Anderson TA. microRNAs as oncogenes and tumor suppressors. Dev Biol 2007, 302:1-12.
71. Lünse CE, MichlewskiG, HoppCS, RentmeisterA, CaceresJF, FamulokM, MayerG An aptamer targeting the apical-loop domain modulates pri-miRNA processing. Angew. Chem. Int. Ed., 2010, 49:4674-4677.